Want to create an interactive transcript for this episode?
Podcast: Dr. Chapa’s OBGYN Clinical Pearls
Episode: Vag E2 After Breast CA: Nah or Yeah?
Description: With improvements in the screening & treatment of Breast Ca, the number of female survivors continues to rise, with a reported 5-year survival rate of up to 90%. However, several of the systemic treatments for breast cancer, including endocrine therapy, chemotherapy, and radiotherapy, can result in a new or worsened hypoestrogenic state. Up to 70% of postmenopausal women will develop symptoms of genitourinary syndrome of menopause (GSM). With an estimated 3.8 million breast cancer survivors in the US, women’s healthcare providers are on the front lines of addressing survivorship issues, including these hypoestrogenic-related adverse effects of cancer therapies or early menopause. This isn’t si...